Anika Therapeutics Raises FY2026 Sales Guidance from $118.460M-$124.101M to $119.588M-$124.101M vs $121.639M Est
Anika Therapeutics (NASDAQ:ANIK) raises FY2026 sales outlook from $118.460 million-$124.101 million to $119.588 million-$124.101 million vs $121.639 million estimate.
Share
Why It Matters
Anika raised its sales forecast a little bit for next year. When a company tweaks guidance slightly up, watch if they keep hitting their targets going forward.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.